• Google

Node Rephine Balticum

Rephine Balticum


Country headquarter:
Market presence:
Latvia, Lithuania, Estonia, Moldova, Ukraine, Georgia, Russian Federation, Azerbaijan, Armenia, Kazakhstan, Kyrgyzstan, Belarus, Uzbekistan, Tadjikistan, Turkmenistan and Israel.
General description:

From a small consulting business Rephine Balticum has grown to an international corporation and has a new division – Inpharmatis.
Rephine Balticum and Inpharmatis offer comprehensive regulatory affairs services to Life Science Industry including Drug Development and Vigilance Services to pharmaceutical, medical device, food supplements, cosmetic and biotech companies. Our area of expertise lies in the European & CIS market.
A multi-disciplinary team of qualified regulatory affairs consultants is at your disposal for all aspects of your marketing authorisation applications for active substances and human medicinal products. Rephine Balticum shall provide full regulatory support over the whole life cycle of your product.

Areas of regulatory/reimbursement support:

We are servicing the Baltic Countries and CIS (ex-Soviet Union) countries for full regulatory, pharmacovigilance, GMP / GDP licensing, and reimbursement support (where possible).

Company website


The eHealth Hub project has received funding from the European Union’s Horizon 2020
Research and Innovation Programme under Grant Agreement No727683.